Cell culture systems for isolation of SARS-CoV-2 clinical isolates and generation of recombinant virus
A simple and robust cell culture system is essential for generating authentic SARS-CoV-2 stocks for evaluation of viral pathogenicity, screening of antiviral compounds, and preparation of inactivated vaccines. Evidence suggests that Vero E6, a cell line commonly used in the field to grow SARS-CoV-2,...
Saved in:
Published in | iScience Vol. 26; no. 5; p. 106634 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
19.05.2023
The Author(s) Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A simple and robust cell culture system is essential for generating authentic SARS-CoV-2 stocks for evaluation of viral pathogenicity, screening of antiviral compounds, and preparation of inactivated vaccines. Evidence suggests that Vero E6, a cell line commonly used in the field to grow SARS-CoV-2, does not support efficient propagation of new viral variants and triggers rapid cell culture adaptation of the virus. We generated a panel of 17 human cell lines overexpressing SARS-CoV-2 entry factors and tested their ability to support viral infection. Two cell lines, Caco-2/AT and HuH-6/AT, demonstrated exceptional susceptibility, yielding highly concentrated virus stocks. Notably, these cell lines were more sensitive than Vero E6 cells in recovering SARS-CoV-2 from clinical specimens. Further, Caco-2/AT cells provided a robust platform for producing genetically reliable recombinant SARS-CoV-2 through a reverse genetics system. These cellular models are a valuable tool for the study of SARS-CoV-2 and its continuously emerging variants.
[Display omitted]
•Human cell lines overexpressing ACE2 and TMPRSS2 were tested for SARS-CoV-2 infection•Two cell lines, Caco-2 and HuH-6, exhibited remarkable susceptibility to infection•Caco-2 and HuH-6 cells allowed isolation of SARS-CoV-2 from clinical specimens•Caco-2 cells supported production of genetically stable recombinant SARS-CoV-2
Methodology in biological sciences; Virology |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Lead contact |
ISSN: | 2589-0042 2589-0042 |
DOI: | 10.1016/j.isci.2023.106634 |